Circulating and tissue forms of the intestinal growth factor, glucagon- like peptide-2

Endocrinology

Volumn 138, Issue 11, 1997, Pages 4837-4843

  Brubaker, Patricia L ^a,b   Crivici, Anna ^c   Izzo, Angelo ^e   Ehrlich, Peter ^a   Tsai, Chun Hui ^a   Drucker, Daniel J ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NPS Pharmaceutical Inc   (United States)

^d Natl Hlth R and D Program   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 2; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE EPITHELIUM; MALE; NONHUMAN; NORMAL HUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN POLYMORPHISM; RADIOIMMUNOASSAY; RAT;

EID: 0030782159     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.11.5482     Document Type: Article

References (37)

1. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF 1986 Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261:11880-11889
2. Orskov C, Holst JJ, Seier Poulsen S, Kirkegaard P 1987 Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-881
3. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide 1 in humans. Diabetes 43:535-539
4. Brubaker PL, So DCY, Drucker DJ 1989 Tissue-specific differences in the levels of proglucagon-derived peptides in streptozotocin-induced diabetes. Endocrinology 124:3003-3009
5. Tucker JD, Dhanvantari S, Brubaker PL 1996 Proglucagon processing in islet and intestinal cell lines. Regul Pept 62:29-35
6. Dhanvantari S, Seidah NG, Brubaker PL 1996 Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10:342-355
7. (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619
8. Kreymann B, Ghatei MA, Williams G, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304
9. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322
10. George SK, Uttenthal LO, Ghiglione M, Bloom SR 1985 Molecular forms of glucagon-like peptides in man. FEBS Lett 192:275-278
11. Orskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV 1986 Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119:1467-1475
12. Orskov C, Holst JJ 1987 Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Gastroenterol 47:165-174
13. Orskov C, Buhl T, Rabenhoj L, Kofod H, Holst JJ 1989 Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS Lett 247:193-196
14. Buhl T, Thim L, Kofod H, Orskov C, Harling H, Holst JJ 1988 Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. J Biol Chem 263:8621-8624
15. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93:7911-7916
16. Tsai CH, Hill M, Drucker DJ 1997 Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 272:G662-G668
17. Brubaker PL, Izzo A, Hill M, Drucker DJ 1997 Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 272:E1050-E1058
18. Schaffalitzky OB, Muckadell DE, Fahrenkrug J 1976 Preparation of 125-I-labelled porcine secretin for radioimmunoassay. Scand J Clin Lab Invest 36:661-668
19. Browne CA, Bennett HPJ, Solomon S 1981 Isolation and characterization of corticotropin- and melanotropin-related peptides from the neurointermediary lobe of the rat pituitary by reversed-phase liquid chromatography. Biochemistry 20:4538-4546
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
21. Schön E, Born I, Demuth H-U, Faust J, Neubert K, Steinmetzer T, Barth A, Ansorge S 1991 Dipeptidyl peptidase IV in the immune system: effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 372:305-311
22. Drucker DJ, Mojsov S, Habener JF 1986 Cell-specific post-translational processing of preproglucagon expressed from a metallothionein-glucagon fusion gene. J Biol Chem 261:9637-9643
23. Drucker DJ, Shi Q, Crivici A, Sumnet-Smith M, Tavares W, Hill M, DeForest L, Cooper S, Brubaker PL 1997 Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nature Biotech 15:673-677
24. Walter R, Simmons WH, Yoshimoto T 1980 Proline specific endo- and exopeptidases. Mol Cell Biochem 30:111-127
25. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V 1993 Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post-prandial and 24-h secretion patterns. J Endocrinol 138:159-166
26. Frohman LA, Downs TR, Williams TC, Heimer EP, Pan Y-CE, Felix AM 1986 Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2-terminus. J Clin Invest 78:906-913
27. Frohman LA, Downs TR, Heimer EP, Felix AM 1989 Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest 83:1533-1540
28. Mentlein R, Gallwitz B, Schmidt WE 1993 Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829-835
29. Kieffer TJ, McIntosh CHS, Pederson RA 1995 Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136:3585-3596
30. Deacon CF, Johnsen AH, Holst JJ 1995 Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80:952-957
31. 2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44:1126-1131
32. Yoshimoto T, Ogita K, Walter R, Koida M, Tsuru D 1979 Post-proline cleaving enzyme: synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochim Biophys Acta 569:184-192
33. Darmoul D, Voisin T, Couvineau A, Rouyer-Fessard C, Salomon R, Wang Y, Swallow DM, Laburthe M 1994 Regional expression of epithelial dipeptidyl peptidase IV in the human intestines. Biochim Biophys Acta 203:1224-1229
34. Darmoul D, Rouyer-Fessard C, Blais A, Voisin T, Sapin C, Baricault L, Cibert C, Geraud G, Couvineau A, Laburthe M, Trugnan G 1991 Dipeptidyl peptidase IV expression in rat jejunal crypt-villus axis is controlled at mRNA level. Am J Physiol 261:G763-G769
35. Lopez-Novoa JM, Santos JC, Villamediana LM, Garrote FJ, Thim L, Moody AJ, Valverde I 1986 Renal catabolism of 125-I-glicentin. Am J Physiol 250:E545-E550
36. Ruiz-Grande C, Pintado J, Alarcón C, Castilla C, Valverde I, López-Novoa JM 1990 Renal catabolism of human glucagon-like peptides 1 and 2. Can J Physiol Pharmacol 68:1568-1573
37. Kervran A, Dubrasquet M, Blache P, Martinez J, Bataille D 1990 Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney. Regul Pept 31:41-52